Literature DB >> 6999358

Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: possible advantages of its use in Candida serology.

M Munoz, G Estes, M Kilpatrick, A Di Salvo, G Virella.   

Abstract

The serology of candidiasis is complicated by the use of poorly defined antigens. Total extracts of the yeast phase have been commonly used as "cytoplasmic' antigen, without regard to the significant amounts of carbohydrate that may contaminate such preparations. This is particularly true in the case of commercially available antigens that have been used as cytoplasmic antigens but actually are richer in carbohydrate than in protein. Affinity chromatography in concanavalin A - Sepharose provides a simple procedure to separate carbohydrates, mainly mannan, from protein antigens in whole Candida extracts. By using mannan-poor antigens, the specificity of serological reactions can be increased considerably, since both the positive reactions seen in a-symptomatic donors and the cross-reactions seen in patients infected with other fungi are due to anti-mannan antibodies. In contrast, both anti-mannan and anti-cytoplasmic antigen antibodies can be detected in patients suspected of systemic candidiasis. On the other hand, absolute specificity may never be achieved for systemic candidiasis. We have found antibodies against cytoplasmic antigen in a patient allergic to C. albicans, in whom the microorganism was isolated from fecal material. It appears that, under favorable conditions, mucosal sensitization may also trigger as systemic reaction directed against both mannan and cytoplasmic antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6999358     DOI: 10.1007/bf00443050

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  33 in total

1.  Current concepts of diagnostic serology and skin hypersensitivity in the mycoses.

Authors:  S B SALVIN
Journal:  Am J Med       Date:  1959-07       Impact factor: 4.965

2.  Detection of candida serum precipitins by counterimmunoelectrophoresis: an adjunct in determining significant candidiasis.

Authors:  T H Dee; M W Rytel
Journal:  J Clin Microbiol       Date:  1977-04       Impact factor: 5.948

3.  Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoreses.

Authors:  R H Glew; H R Buckley; H M Rosen; R C Moellering; J E Fischer
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

4.  Serological evidence of Candida infection after open-heart surgery.

Authors:  I G Murray; H R Buckley; G C Turner
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

5.  Three serologic tests for candidiasis. Diagnostic value in distinguishing deep or disseminated infection from superficial infection or colonization.

Authors:  S A Harding; G R Sandford; W G Merz
Journal:  Am J Clin Pathol       Date:  1976-06       Impact factor: 2.493

6.  Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study.

Authors:  W G Merz; G L Evans; S Shadomy; S Anderson; L Kaufman; P J Kozinn; D W Mackenzie; W P Protzman; J S Remington
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

Review 7.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

8.  Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A.

Authors:  J H Ellsworth; E Reiss; R L Bradley; H Chmel; D Armstrong
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

9.  Evaluation of candida precipitin and agglutinin tests for the diagnosis of systemic candidiasis in burn patients.

Authors:  I A Holder; P J Kozinn; E J Law
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

10.  Evaluation of the antigen specific to the mycelial phase of Candida albicans in the serodiagnosis of candidiasis.

Authors:  T Umenai; H Chiba
Journal:  Tohoku J Exp Med       Date:  1977-12       Impact factor: 1.848

View more
  7 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.

Authors:  J P Burnie; R C Matthews; A Fox; S Tabaqchali
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

Review 3.  New developments in the diagnosis of opportunistic fungal infection.

Authors:  V Hopwood; D W Warnock
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

4.  Circulating immune complexes in patients with Candida albicans infections.

Authors:  G Burges; H P Holley; G Virella
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Cellular and humoral immune responses to Candida albicans in subcutaneously infected mice.

Authors:  J Ponton; G Quindos; P Regulez; R Cisterna
Journal:  Mycopathologia       Date:  1985-10       Impact factor: 2.574

6.  Evaluation of enzyme-linked immunosorbent assays for detecting circulating antibodies to Candida albicans.

Authors:  Harry E Prince; Cindy Yeh; Navid Alem; Mandana Asalkhou; Nina Hamedi; Neda Alem; Mehdi Alem
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

7.  Evaluation of the antigen from chlamydospores of Candida albicans in the serodiagnosis of candidiasis.

Authors:  G Caretta; G Del Frate; M Guglielminetti
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.